The NovaSeq X Series is Illumina's most powerful sequencing system, delivering an unprecedented combination of high throughput and accuracy, and featuring streamlined informatics, breakthrough ...

Illumina’s announced partnerships with IBM’s Watson and Philips help shore up the firm's data-analysis capabilities and clinical diagnostic marketing efforts, respectively, but the announcement of a ...

SAN DIEGO, October 3, 2022 /CSRwire/ - lllumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, announced the launch of the NovaSeq™ X Series (NovaSeq X and ...

Illumina has begun rolling out a series of updates to its top-of-the-line DNA sequencer models, with the goal of making the high-throughput machines more attractive to smaller laboratories. For its ...

Illumina, Inc. ILMN recently reached a major milestone by surpassing over 200 orders for its revolutionary NovaSeq X sequencing system in the first quarter of 2023. Strong customer demand drives ...

Propel your research forward to impact the world, not the environment. The NovaSeq X and NovaSeq X Plus systems were purpose-designed to be our most sustainable sequencing systems with reductions in ...

San Diego’s Illumina is getting closer to sequencing full human genomes at a cost that’s considered the sweet spot for driving wider adoption of personalized medicine based on a patient’s DNA. At its ...

Illumina is welcoming a new addition to its DNA sequencing lineup, with a pair of accessible benchtop instruments that incorporate the tech and chemistry used by its largest, top-of-the-line machines.

Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced that its first product based on its novel Illumina Complete Long Read technology is now ...

SAN DIEGO — After a steep drop in its stock price and with mounting competition from rivals, genomics giant Illumina on Thursday launched a new line of high-powered DNA sequencers, ratcheting up the ...